Key result
lncRNA-p21 activates the SESN2/AMPK/TSC2 pathway to enhance autophagy, protecting against AngII-induced endothelial progenitor cell damage in hypertension.
Why the study?
Functional damage and decreased EPCs occur in hypertensive patients, but the underlying mechanism remains unelucidated.
Does lncRNA-p21 protect against endothelial progenitor cell damage in hypertension?
Does lncRNA-p21 protect against endothelial progenitor cell damage in hypertension?
Answers are grounded in this paper and cite their sources.
lncRNA-p21 represents a potential novel therapeutic target for vascular endothelial repair in hypertension by reversing decreased autophagy in endothelial progenitor cells.
Vascular damage of hypertension has been the focus of hypertension treatment, and endothelial progenitor cells (EPCs) play an important role in the repair of vascular endothelial damage. Functional damage and decreased number of EPCs are observed in the peripheral circulation of hypertensive patients, but its mechanism is not yet elucidated. Here, we show that the number of EPCs in hypertensive patients is significantly lower than that of normal population, and the cell function decreases with a higher proportion of EPCs at later stages. A decrease in autophagy is responsible for the senescence and damage of EPCs induced by AngII. Moreover, lncRNA-p21 plays a critical regulator role in EPCs' senescence and dysfunction. Furthermore, lncRNA-p21 activates SESN2/AMPK/TSC2 pathway by promoting the transcriptional activity of p53 and enhances autophagy to protect against AngII-induced EPC damage. The data provide evidence that a reversal of decreased autophagy serves as the protective mechanism of EPC injury in hypertensive patients, and lncRNA-p21 is a new therapeutic target for vascular endothelial repair in hypertension.
No takes yet. Share an insight, caveat, or question.
Li et al. (2021) studied Hypertension. lncRNA-p21 vs. Control was evaluated on Endothelial progenitor cell senescence and damage. lncRNA-p21 activates the SESN2/AMPK/TSC2 pathway to enhance autophagy, protecting against AngII-induced endothelial progenitor cell damage in hypertension.
Synapse has enriched 10 related papers. Consider them for comparative context: